BackAdial Pharmaceuticals- Warrants (31/07/2023) Overview

Adial Pharmaceuticals- Warrants (31/07/2023) EBIT

EBIT (Earnings Before Interest and Taxes) analysis for ADILW.

Quarterly EBIT

-$2.00M
11.72% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

-$7.53M
13.47% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)